Ophthalmological research in Germany: suggestions by an international expert panel
Die Ophthalmologie · 2025
DOI: 10.1007/s00347-024-02048-y ↗Kurz gefasst
Fachartikel in der Zeitschrift Die Ophthalmologie, 2025. Verfasst von Marius Ader und 11 weiteren Autor:innen. Beteiligte Einrichtung: CRTD/Center for Regenerative Therapies Dresden, Center for Molecular and Cellular Bioengineering (CMCB), Technische Universität Dresden, Fetscherstra…. Hauptthemen laut MEDLINE: Ophthalmology, Biomedical Research. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 7 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitätsklinikum Köln.
Abstract (Originalsprache)
Purpose
To evaluate the research performance in ophthalmology in Germany based on the findings of the recent research map of the German Ophthalmological Society (DOG) and to suggest strategies for future improvements on a national level both to DOG as well as to politics. The focus is on preclinical and translational clinical research.
Methods
International expert panel evaluation and discussion organized by the Task Force Research of the German Ophthalmological Society (DOG).
Results
The international view on the German ophthalmological research landscape was generally positive. The value for money relationship was judged as very good. As Germany is facing an aging society and vision impairment will create an ever-increasing socioeconomic burden, the reviewers suggested several lines of future activities: an increased activity of securing intellectual property, more lay audience lobbying, intensified collaboration and critical mass building between “lighthouses” of ophthalmic research in Germany, as well as the establishment of a German national eye institute equivalent.
Conclusion
The ophthalmological research performance in Germany was rated to be very good by an international expert panel. Nonetheless significant improvements were requested in the fields of translation (clinical trials, IP), synergy between specialized institutions and governmental funding for a German center for eye research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- CRTD/Center for Regenerative Therapies Dresden, Center for Molecular and Cellular Bioengineering (CMCB), Technische Universität Dresden, Fetscherstraße 105, 01307, Dresden, Germany.
- Department of Ophthalmology, University Hospital of Cologne, Cologne, Germany. claus.cursiefen@uk-koeln.de.
- Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany. claus.cursiefen@uk-koeln.de.
- Department of Ophthalmology, University Hospital of Cologne, Cologne, Germany.
- F. Hoffmann-La Roche, Basel, Switzerland.
- Boehringer Ingelheim GmbH, Ingelheim am Rhein, Germany.
Förderung
- Universitätsklinikum Köln
Zitieren
APA
Ader, M., Cursiefen, C., Fauser, S., Gliem, M., Helbig, H., Lagrèze, W., Marshall, J., Roesky, C., Sahel, J. A., Schlötzer-Schrehard, U., Sieving, P., & Ueffing, M. (2025). Ophthalmological research in Germany: suggestions by an international expert panel. Die Ophthalmologie. https://doi.org/10.1007/s00347-024-02048-y
Vancouver
Ader M, Cursiefen C, Fauser S, Gliem M, Helbig H, Lagrèze W, et al. Ophthalmological research in Germany: suggestions by an international expert panel. Die Ophthalmologie. 2025. doi:10.1007/s00347-024-02048-y
BibTeX
@article{Ader2025,
author = {Ader, Marius and Cursiefen, Claus and Fauser, Sascha and Gliem, Martin and Helbig, Horst and Lagrèze, Wolf and Marshall, John and Roesky, Christian and Sahel, José-Alain and Schlötzer-Schrehard, Ursula and Sieving, Paul and Ueffing, Marius},
title = {Ophthalmological research in Germany: suggestions by an international expert panel},
journal = {Die Ophthalmologie},
year = {2025},
doi = {10.1007/s00347-024-02048-y}
}
EUVIMED